RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.11
-0.10 (-1.22%)
At close: Oct 9, 2025, 4:00 PM EDT
8.12
+0.01 (0.12%)
After-hours: Oct 9, 2025, 7:28 PM EDT
RxSight Employees
RxSight had 498 employees as of December 31, 2024. The number of employees increased by 124 or 33.16% compared to the previous year.
Employees
498
Change (1Y)
124
Growth (1Y)
33.16%
Revenue / Employee
$295,299
Profits / Employee
-$64,763
Market Cap
331.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 498 | 124 | 33.16% |
| Dec 31, 2023 | 374 | 82 | 28.08% |
| Dec 31, 2022 | 292 | 71 | 32.13% |
| Dec 31, 2021 | 221 | 50 | 29.24% |
| Dec 31, 2020 | 171 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RXST News
- 17 days ago - The Bottom Fishing Club - RxSight: A Ski-Jump Reversal Pattern? - Seeking Alpha
- 17 days ago - RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST - PRNewsWire
- 18 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewsWire
- 23 days ago - DEADLINE NEXT WEEK: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Contact the Firm Before September 22, 2025 - GlobeNewsWire
- 25 days ago - RXST STOCK NEWS: RxSight, Inc. Investors Urged to Act by September 22 Court Deadline -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 27 days ago - RXST SECURITIES NOTICE: Did RxSight, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment - GlobeNewsWire
- 4 weeks ago - RxSight, Inc. (RXST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - PRNewsWire